Tradestie Institutional Equity Comparison Engine
PYPD vs OBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PYPD Overall Edge
PYPD Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PolyPid Ltd. Ordinary Shares (PYPD) driven by superior Growth & Margin, Momentum & Technical while OBIO counters with relative strength in Options & Structure. Fundamentally, PYPD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OBIO at N/M Forward P/E and -195.4% operating margin (-89.4% YoY). In options structure, PYPD sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro) against OBIO sits in BREAKOUT (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PYPD N/M vs OBIO N/M Fwd P/E
Growth & Margin Winner
PYPD
Op Margin 0.0% vs -195.4% ยท YoY +0.0% vs -89.4%
Momentum & Technical Winner
PYPD
1Y +79.2% vs +79.4% ยท 52W Pos 80% vs 90%
Options & Structure Winner
OBIO
BREAKOUT (12th %ile IV) vs BREAKOUT (<1st %ile IV)
PYPD
NASDAQ
PolyPid Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$6.43
+4.63% 1D
Market Cap
$132.2M
1M Return
+31.86%
1Y Return
+79.25%
Forward P/E
N/M
Unified AI Score
31.1 / 100
SELL
Tech 50.0
Fund 27.0
Flow 56.0
Mom 32.0
OBIO
NASDAQ
Orchestra BioMed Holdings, Inc. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$7.07
-0.7% 1D
Market Cap
$570.6M
1M Return
+25.13%
1Y Return
+79.44%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 15.0
Fund 40.0
Flow 62.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PYPD +79.25%
OBIO +79.44%
Spread: +0.19 pp (OBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PYPD TTM Op. Margin: 0.0%
OBIO TTM Op. Margin: -195.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PYPD vs OBIO. Trailing 12-month operating profitability (PYPD 0.0% vs OBIO -195.4%) and valuation multiples (PYPD N/M vs OBIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PYPD | OBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $570.6M | Larger Scale | OBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -89.4% | Higher Growth | PYPD |
| Operating Margin (TTM) Profitability | 0.0% | -195.4% | Higher Margin | PYPD |
| Net Profit Margin Profitability | 0.0% | -182.5% | Higher Margin | PYPD |
| Return on Equity (ROE) Capital Efficiency | -243.6% | -182.3% | Higher ROE | OBIO |
| 52-Week Range Position Momentum | 80% ($4โ$7) | 90% ($3โ$7) | Stronger Trend | OBIO |
| Beta / 30D Volatility Risk Regime | 0.89ฮฒ ยท 59% Vol | 1.15ฮฒ ยท 80% Vol | Lower Realized Risk | PYPD |
| Unified Institutional Score Composite Signal | 31.1 / 100 (SELL) | 42.9 / 100 (HOLD) | Higher Composite | OBIO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PYPD vs OBIO Buy Guide
PYPD
BREAKOUT
40d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
OBIO
BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PYPD nor OBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.